Skip to content
Stock screener

HCA HCA Healthcare, Inc. stock chart & analysis

Conviction 27HealthcareScan · Fri, Nov 6, 2026

HCA Healthcare, Inc. (HCA) closed at $494.99 (-2.46%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 62, RS Rating 84, -11.1% from its 52-week high, +6.0% year to date. Sector: Healthcare · Services-General Medical & Surgical Hospitals, Nec.

HCA$494.99-2.46%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
HCA Healthcare, Inc.Services-General Medical & Surgical Hospitals, Necwww.hcahealthcare.com ↗
Price494.99
Change-2.46%
Gap-1.97%
Rel volume0.73×
Avg volume1.45M
Avg $ vol683.71M
SMA 20470.34
SMA 50443.61
SMA 200444.86
Price vs 50+11.56%
Price vs 200+11.25%
MA stackmixed
50/200 cross—
Supertrendup · 454.89
RSI (14)62
MACD hist2.78
MACD crossbull · 2d
Stoch %K / %D67 / 82
ADX (14)26
+DI / −DI33 / 17
RSI divergence—
MACD divergence—
ATR %3.50%
ADR %3.25%
52w high556.52
52w low353.99
From 52w high-11.07%
Above 52w low+39.81%
New 52w highNo
SqueezeOff
Bollinger width13.43%
%B0.89
Donchian pos67.46%
Donchian high521.48
Donchian low439.83
AVWAP (52w high)424.52
vs AVWAP high+16.58%
AVWAP (52w low)425.38
vs AVWAP low+16.35%
OBV trendFlat
Chaikin MF (20)0.05
Today vs 20d0.73×
Avg vol (14d)1.56M
Avg vol (20d)1.45M
Avg $ vol (20d)683.71M
Market cap103.38B
RS Rating84 / 99
RS 3m (vs SPY)+24.40%
RS 6m (vs SPY)+14.02%
RS line new highNo
Trend template5/8
Technical rank90.5
1 week+4.59%
1 month+11.21%
3 months+19.53%
6 months+13.72%
1 year+4.59%
YTD+6.01%
P/E15.24
P/B-12.80
P/S1.37
P/FCF13.44
EPS28.33
Div yield0.66%
ROE-83.99%
ROA10.69%
Debt/Eq-6.25
Current0.82
EV/EBITDA—
Gross margin—
Net margin8.97%
Rev growth7.08%
EPS growth17.78%
Price target462.57
Target upside-6.53%
Analyst ratingBuy
Institutional70.18%
Ent. value152.97B
Revenue19.85B
Net income1.58B
Gross profit—
Free cash flow7.69B
IndustryServices-General Medical & Surgical Hospitals, Nec
ExchangeNYSE
Shares out—
Employees320K
ListedThu, Mar 10, 2011
Free float180.22M
Float %81.2%
Short interest—
Days to cover—
Short volume57.9%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$7.22 vs $6.74
Last surprise+7.1% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank90.5 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance486.86
Support421.96
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

HCA technical analysis

Trend

HCA's moving averages are mixed — no clean uptrend or downtrend. It closed 11.6% above the 50-day ($443.61) and 11.3% above the 200-day ($444.86). ADX(14) at 26 points to a strong, established trend. It meets 5 of 8 trend-template criteria.

Momentum

RSI(14) is 62, in the bullish half of its range. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 84 puts its weighted 12-month performance ahead of about 84% of the US market.

Volume and volatility

Volume on the latest session ran 0.7× its 20-day average. It trades about $683.7M a day on average. ATR(14) is $17.30, 3.5% of price — its typical daily range.

Key levels

The chart pattern's support is $421.96 and its resistance $486.86. The 52-week range is $353.99 to $556.52; price is 11.1% below the high and 39.8% above the low. The VWAP anchored at the 52-week high is $424.52, below price.

Performance

HCA returned +4.6% (1 week), +11.2% (1 month), +19.5% (3 months), +13.7% (6 months), +4.6% (1 year), +6.0% (year to date).

About HCA Healthcare, Inc.

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

Services-General Medical & Surgical Hospitals, Nec · Listed 2011 · 320,000 employees

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 18 – Oct 6
    5 scans
  2. Breaking out now
    Oct 7
    1 scan
  3. Broke out
    Oct 8 – Oct 9
    2 scans
  4. Setting up
    Oct 23 – Oct 26
    2 scans

Congress activity

Disclosed STOCK Act trades in HCA · 9 recent

All disclosures →
MemberSideAmount
Jared Moskowitz
Jared Moskowitz
house · D · FL · traded 2026-06-17
Buy$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-09-11
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-10-29
Buy$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-12-27
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-08-19
Buy$1K–$15K
Jared Moskowitz
Jared Moskowitz
house · D · FL · traded 2025-05-15
Buy$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-04-07
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-02-25
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in HCA · open-market 8 sells

InsiderSideShares
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell1.07K
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell2.69K
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell7.59K
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell6.3K
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell1.48K
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell890
Foster Jon M
EVP and COO · Common Stock · 2026-11-06
Sell1.68K
Foster Jon M
EVP and COO · Common Stock · 2026-11-04
Dispose16.14K
Foster Jon M
EVP and COO · Stock Appreciation Right · 2026-11-04
Exercise35.88K
Schlosser Michael J
EVP and Chief Clinical Officer · Common Stock · 2026-11-04
Sell1.2K

SEC filings

EDGAR filings in HCA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.